MTOR and gastric cancer: Met-TKIs induced protective autophagy via Met/mTOR/ULK1 cascade and Met-TKIs combined with autophagy inhibitors augmented antitumor activity in Met-amplified GC preclinical models, shedding light upon this combination strategy in the treatment of Met-amplified GC.